Drug Screening Market Competitive Landscape
Key players operating in the global drug screening market include Thermo Fisher Scientific, Quest Diagnostics, Omega Laboratories, Abbott Laboratories, Danaher Corporation, Express Diagnostics International Inc., Siemens Healthineers, Alfa Scientific Designs, F. Hoffmann La Roche, SureHire, and OraSure.
Drug screening involves testing of the samples such as urine, breath, oral fluid, hair, and others for presence of any substances over the limit. The significance of the drug screening is that a person under influence of the drugs or alcohol is liable for road accidents, and other workplace issues.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/drug-screening-market-1696
Manufacturers such as Abbott Laboratories provide drug screening tests for testing purposes at workplace, in government organizations, rehabilitation centers, and other places. These tests are painless and non-invasive. Moreover, manufacturers such as Alere, Inc. (part of Abbott Laboratories) provide point-of-care diagnostic tests for drug screening. Furthermore, drug addict individuals involved in certain professions such as an air traffic controller, and commercial drivers can risk safety of others, which can be avoided by pre-employment urine testing. On-the-job accidents could also be reduced with the help of drug screening. A urine drug test is painless and analyzes presence of prescription drugs such as amphetamines, methamphetamines, benzodiazepines, marijuana, barbiturates, cocaine, methadone, and opioids (narcotics).
Drug Screening Market Drivers
Competition among leading manufacturers in the drug screening market is supporting the growth of the drug screening market. Manufacturers are engaged in developing innovative products in wide categories in order to maintain leading position in the market. Alere, Inc. along with its partner company GenPrime, Inc., launched point of care testing device, the xReader for work-place drug testing in 2016. In 2017, Alere, Inc. launched Alere iCup Rx drug screen for detecting commonly misused and abused prescription drugs. Moreover, technological advancements are expected to boost growth of the drug screening market over the forecast period. For instance, Intelligent Fingerprinting Limited launched non-invasive portable fingerprint drug test in 2017.
Request a sample to stay abreast on the key trends impacting this market: https://www.coherentmarketinsights.com/insight/request-sample/1696
Drug Screening Market Insights
North America and Europe are expected to dominate the drug screening market over the forecast period due to presence of leading manufacturers such as Alere, Inc. Mergers and acquisitions by key players are expected to foster growth of the market such as Abbott Laboratories acquisition of Alere, Inc. in 2017. Asia Pacific region is expected to witness significant growth over the forecast period, owing to increasing presence of leading manufacturers in the region.
Drug Screening Market Taxonomy-
The global drug screening market is segmented on the basis of product type, application, end user, and region.
By Product Type:
- Immunoassay analyzers
- Chromatography Instruments
- Drug testing Cups
- Dip Cards
- Oral Fluid Testing Products
- Urine Testing
- Breath Testing
- Oral Fluid Testing
- Hair Testing
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.